Table 2 Summary of recovery results of 50 µmol L−1 AMX from tablet solutions containing 25 µM APF and EPHARM brand tablets
Tablet brand | Intial AMX content/(µmol L−1) | Spiked AMX (µmol L−1) | Detected AMX (µmol L−1)a | Recovery (%) |
|---|---|---|---|---|
APF | 25 | – | 25.08 ± 6.52 | – |
25 | 50 | 75.33 ± 7.15 | 100.5 | |
EPHARM | 25 | – | 24.30 ± 5.78 | – |
25 | 50 | 74.10 ± 6.12 | 99.6 |